Lebenthal Global Advisors’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Buy |
63,132
+4,471
| +8% | +$29.8K | 0.08% | 145 |
|
|
2025
Q1 | $380K | Buy |
58,661
+13,078
| +29% | +$84.6K | 0.07% | 152 |
|
|
2024
Q4 | $367K | Buy |
45,583
+901
| +2% | +$7.26K | 0.07% | 154 |
|
|
2024
Q3 | $365K | Buy |
44,682
+169
| +0.4% | +$1.38K | 0.07% | 146 |
|
|
2024
Q2 | $310K | Buy |
44,513
+28
| +0.1% | +$195 | 0.07% | 152 |
|
|
2024
Q1 | $472K | Sell |
44,485
-13,372
| -23% | -$142K | 0.1% | 122 |
|
|
2023
Q4 | $464K | Buy |
57,857
+8,633
| +18% | +$69.2K | 0.11% | 121 |
|
|
2023
Q3 | $405K | Sell |
49,224
-11,200
| -19% | -$92.1K | 0.12% | 90 |
|
|
2023
Q2 | $483K | Sell |
60,424
-16,353
| -21% | -$131K | 0.14% | 75 |
|
|
2023
Q1 | $622K | Buy |
76,777
+993
| +1% | +$8.04K | 0.19% | 58 |
|
|
2022
Q4 | $476K | Buy |
75,784
+32,195
| +74% | +$202K | 0.16% | 74 |
|
|
2022
Q3 | $300K | Buy |
43,589
+56
| +0.1% | +$385 | 0.14% | 89 |
|
|
2022
Q2 | $363K | Buy |
43,533
+8,644
| +25% | +$72.1K | 0.18% | 89 |
|
|
2022
Q1 | $797K | Buy |
34,889
+9,175
| +36% | +$210K | 0.34% | 44 |
|
|
2021
Q4 | $709K | Buy |
25,714
+1,456
| +6% | +$40.1K | 0.29% | 45 |
|
|
2021
Q3 | $675K | Buy |
24,258
+43
| +0.2% | +$1.2K | 0.42% | 43 |
|
|
2021
Q2 | $710K | Buy |
24,215
+6,645
| +38% | +$195K | 0.38% | 42 |
|
|
2021
Q1 | $557K | Sell |
17,570
-6,305
| -26% | -$200K | 0.34% | 39 |
|
|
2020
Q4 | $494K | Buy |
+23,875
| New | +$494K | 0.35% | 33 |
|